First-pass extracted concept

non-genetic surface modification

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

polymer-coating approaches

Evidence Snippets

This review summarizes recent advances in redirecting AAV tropism toward endothelial cells (ECs) through genetic capsid engineering, peptide display, and non-genetic surface modification. In addition, we discuss polymer-coating approaches that allow receptor-specific targeting of ECs with reduced recognition by immune cells.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanismsupports2026Source 1DOI PubMed

Polymer-coating approaches can allow receptor-specific targeting of endothelial cells with reduced recognition by immune cells.

Quoted textsource-backed

polymer-coating approaches that allow receptor-specific targeting of ECs with reduced recognition by immune cells

Claim 2overall conclusionsupports2026Source 1DOI PubMed

Endothelial-retargeting strategies for AAV are promising for enhancing vascular tropism and transduction efficiency and may enable precise vascular gene therapies.

Quoted textsource-backed

Together, these strategies represent promising avenues for enhancing vascular tropism and transduction efficiency of modified AAVs, moving the field closer to precise vascular gene therapies.

Claim 3strategy summarysupports2026Source 1DOI PubMed

AAV tropism can be redirected toward endothelial cells through genetic capsid engineering, peptide display, and non-genetic surface modification.

Quoted textsource-backed

This review summarizes recent advances in redirecting AAV tropism toward endothelial cells (ECs) through genetic capsid engineering, peptide display, and non-genetic surface modification.